Seite drucken
Publikationen  / 2009

Publikationen 2009


Attig S, Hennenlotter J, Pawelec G, Klein G, Koch SD, Pircher H, Feyerabend S, Wernet D, Stenzl A, Rammensee HG, Gouttefangeas C. Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas. Cancer Res. 69(21):8412-9; 2009. PubMed

Berg CP, Kannan TR, Klein R, Gregor M, Baseman JB, Wesselborg S, Lauber K, Stein GM. Mycoplasma antigens as a possible trigger for the induction of antimitochondrial antibodies in primary biliary cirrhosis. Liver Int. 29:797-809; 2009.  PubMed

Berg CP, Schlosser SF, Neukirchen DK, Papadakis C, Gregor M, Wesselborg S, Stein GM. Hepatitis C virus core protein induces apoptosis-like caspase independent cell death. Virol J. 6:213; 2009.  PubMed

Blume KE, Soeroes S, Waibel M, Keppeler H, Wesselborg S, Herrmann M, Schulze-Osthoff K, Lauber K. Cell surface externalization of annexin A1 as a failsafe mechanism preventing inflammatory responses during secondary necrosis. J Immunol. 183:8138-8147; 2009.  PubMed

Dieterle A, Orth R, Daubrawa M, Grotemeier A, Alers S, Ullrich S, Lammers R, Wesselborg S, Stork B. The Akt inhibitor triciribine sensitizes prostate carcinoma cells to TRAIL-induced apoptosis. Int J Cancer 15:932-41; 2009.  PubMed

Feuchtinger T, Pfeiffer M, Pfaffle A, Teltschik HM, Wernet D, Schumm M, Lotfi R, Handgretinger R, Lang P. Cytolytic activity of NK cell clones against acute childhood precursor-B-cell leukaemia is influenced by HLA class I expression on blasts and the differential KIR phenotype of NK clones. Bone Marrow Transplant. 43(11):875-81; 2009. PubMed

Feldhahn M, Dönnes P, Thiel P, Kohlbacher O. FRED--a framework for T-cell epitope detection. Bioinformatics 25(20):2758-9; 2009.  PubMed

Feyerabend S, Stevanovic S, Gouttefangeas C, Wernet D, Hennenlotter J, Bedke J, Dietz K, Pascolo S, Kuczyk M, Rammensee HG, Stenzl A. Novel multi-peptide ination in HLA-A2+ hormone sensitive patients with biochemical relapse of prostate cancer. Prostate 69 (9):917-27; 2009.  PubMed

Ghavami S, Eshraghi M, Kadkhoda K, Mutawe MM, Maddika S, Bay GH, Wesselborg S, Halayko AJ, Klonisch T, Los M. Role of BNIP3 in TNF-induced cell death – TNF upregulates BNIP3 expression. Biochim Biophys Acta 1793:546-60; 2009.  PubMed

Gille C, Steffen F, Lauber K, Keppeler H, Leiber A, Spring B, Poets CF, Orlikowsky TW. Clearance of apoptotic neutrophils is diminished in cord blood monocytes and does not lead to reduced IL-8 production. Pediatr Res. 66:507-512; 2009;   PubMed

Göhring K, Feuchtinger T, Mikeler E, Lang P, Jahn G, Handgretinger R, Hamprecht K. Dynamics of the emergence of a human cytomegalovirus UL97 mutant strain conferring ganciclovir resistance in a pediatric stem-cell transplant recipient. J Mol Diagn, 28: 364-368; 2009. PubMed

Klug F, Miller M, Schmidt HH, Stevanovic S. Characterization of MHC ligands for peptide based tumor vaccination. Curr Pharm Des. 15:3221-3236; 2009.  PubMed

Kneilling M, Mailhammer R, Hültner L, Schönberger T, Fuchs K, Schaller M, Bukala D, Massberg S, Sander CA, Braumüller H, Eichner M, Maier KL, Hallmann R, Pichler BJ, Haubner R, Gawaz M, Pfeffer K, Biedermann T, Röcken M. Direct crosstalk between mast cell-TNF and TNFR1-expressing endothelia mediates local tissue inflammation. Blood 114(8):1696-706; 2009. PubMed

Kopp HG, Placke T, Salih HR. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. Cancer Res. 69(19):7775-83; 2009. PubMed

Kuttruff S, Koch S, Kelp A, Pawelec G, Rammensee HG, Steinle A. NKp80 defines and stimulates a reactive subset of CD8 T cells. Blood. 113(2):358-69; 2009.  PubMed

Lupescu A, Geiger C, Zahir N, Aberle S, Lang PA, Kramer S, Wesselborg S, Kandolf R, Foller M, Lang F, Bock CT. Inhibition of Na+/H+ exchanger activity by parvovirus B19 protein NS1. Cell Physiol Biochem. 23:211-20; 2009.  PubMed

Luther C, Adamopoulou E, Stoeckle C, Brucklacher-Waldert V, Rosenkranz D, Stoltze L, Lauer S, Poeschel S, Melms A, Tolosa E. Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients. J Immunol. 15;183(2):841-8; 2009. PubMed

Maddika S, Panigrahi S, Wiechec E, Wesselborg S, Fischer U, Schulze-Osthoff K, Los M. Unscheduled Akt-triggered Activation of CDK2 as a Key Effector Mechanism of Apoptin’s Anticancer Toxicity. Mol Cell Biol. 29:1235-48; 2009.  PubMed

Meyer VS, Drews O, Günder M, Hennenlotter J, Rammensee HG, Stevanovic S. Identification of natural MHC class II presented phosphopeptides and tumor-derived MHC class I phospholigands. J Proteome Res. 8:3666-3674; 2009.  PubMed

Persson BD, Müller S, Reiter DM, Schmitt BB, Marttila M, Sumowski CV, Schweizer S, Scheu U, Ochsenfeld C, Arnberg N, Stehle T. An arginine switch in the species B adenovirus knob determines high-affinity engagement of cellular receptor CD46. J Virol. 83(2):673-86; 2009. PubMed

Queck SY, Khan BA, Wang R, Bach TH, Kretschmer D, Chen L, Kreiswirth BN, Peschel A, Deleo FR, Otto M. Mobile genetic element-encoded cytolysin connects virulence to methicillin resistance in MRSA. PLoS Pathog. 5(7):e1000533; 2009. PubMed

Schmidt SM, König T, Bringmann A, Held S, von Schwarzenberg K, Heine A, Holderried TA, Stevanovic S, Grünebach F, Brossart P. Characterization of BAX inhibitor-1 as a novel leukemia-associated antigen.  Leukemia 23:1818-1824; 2009.  PubMed

Sobiesiak M, Shumilina E, Lam RS, Wölbing F, Matzner N, Kaesler S, Zemtsova IM, Lupescu A, Zahir N, Kuhl D, Schaller M, Biedermann T*, Lang F*. Impaired mast cell activation in gene-targeted mice lacking the serum- and glucocorticoid-inducible kinase SGK1.  J Immunol. 183(7):4395-402; 2009. *Corresponding authors. PubMed

Stickel JS, Weinzierl AO, Hillen N, Drews O, Schuler MM, Hennenlotter J, Wernet D, Müller CA, Stenzl A, Rammensee HG, Stevanovic S. HLA ligand profiles of primary renal cell carcinoma maintained in metastases. Cancer Immunol Immunother. 58:1407-141; 2009.  PubMed

Stoeckle C, Gouttefangeas C, Hammer M, Weber E, Melms A, Tolosa E. Cathepsin W expressed exclusively in CD8+ T cells and NK cells, is secreted during target cell killing but is not essential for cytotoxicity in human CTLs. Exp Hematol. 37(2):266-75; 2009. PubMed

Stoeckle C, Sommandas V, Adamopoulou E, Belisle K, Schiekofer S, Melms A, Weber E, Driessen C, Boehm BO, Tolosa E, Burster T.  Cathepsin G is differentially expressed in primary human antigen-presenting cells. Cell Immunol. 255(1-2):41-5; 2009. PubMed

Toussaint NC, Kohlbacher O. OptiTope--a web server for the selection of an optimal set of peptides for epitope-based vaccines. Nucleic Acids Res. 37(Web Server issue):W617-22; 2009.  PubMed

Toussaint NC, Kohlbacher O. Towards in silico design of epitope-based vaccines. Expert Opin Drug Discov. 4:1047-1060; 2009.

Weber HO, Fischer J, Kneilling M, Caroli U, Rocken M, Biedermann T.  Recall urticaria induced by skin tests with heparin. Br J Dermatol. 161(1):187-9; 2009. PubMed

Weide B, Pascolo S, Scheel B, Derhovanessian E, Pflugfelder A, Eigentler TK, Pawelec G, Hoerr I, Rammensee HG, Garbe C. Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients. J Immunother. 32(5):498-507; 2009. PubMed

Ziegler A, Heidenreich R, Braumuller H, Wolburg H, Weidemann S, Mocikat R, Rocken M (2009) EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion. Blood 113(15):3494-502; 2009. PubMed



Keine News in dieser Ansicht.

   Werbeagentur: |